Reading Level

Generative AI helps to design new drug candidates

● AI models, not dissimilar to ChatGPT in the field of languages, are designing new compounds and speeding up the pharmaceutical industry’s quest to develop new drugs.
● Building on traditional research and existing test data, the new AIs enable laboratories to gain time and optimise drug candidates’ chances of success in clinical trials.
● Deploying the power of reinforcement learning, the new machines can take into account innumerable parameters and evaluate the eligibility of compounds in just a few milliseconds.
Read the article

Green and Local Energy Exchanges and Optimizing Network Consumption

Read the article

Surveillance, climate change and astronomy: AI reveals insights in space data

Read the article

Connected Car Payments Are Moving Up a Gear

Read the article
Two women discuss over code displayed on the computer screen

Ecodesign Fosters Sustainable Digital Practices and Services

Read the article

Faster more accurate diagnoses and machines that can “read” your mind: the AI revolution in scanning

Read the article
Printed organic electronics

Printable and environmentally friendlier: the potential benefits of organic semiconductors

Read the article